Drug · DIN 02568748
IDVYNSO
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 3, 2026.
- Drug Identification Number (DIN)
- 02568748
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Non-nucleoside reverse transcriptase inh J05AG
- Class
- Human
- Record last updated
- June 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DORAVIRINE | 100 MG | |
| ISLATRAVIR | 0.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 3, 2026: NOC 37657New Drug Submission (NDS)